Literature DB >> 2446731

Respiratory syncytial virus fusion glycoprotein: further characterization of a major epitope involved in virus neutralization.

M Trudel1, F Nadon, C Séguin, P Payment, P J Talbot.   

Abstract

Competition experiments and biological assays with a panel of 15 monoclonal antibodies confirmed the presence of at least four antigenic sites on the fusion protein of human respiratory syncytial virus, three of which were involved in virus neutralization. One antigenic site, recognized by two strongly neutralizing antibodies, was conserved after reduction and denaturation and shown by immunoblotting to be localized on the F1 fragment of the fusion protein. Cleavage of this protein with staphylococcal protease V8 or papain produced a series of smaller peptides from 11 to 7 kilodaltons that retained this important neutralization determinant. Compared with the other neutralization sites, the epitope defined by monoclonal antibody 7C2 thus appears as the major neutralization epitope. Our peptide mapping results support the hypothesis that this major epitope is composed of a continuous sequence on the viral genome.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2446731     DOI: 10.1139/m87-164

Source DB:  PubMed          Journal:  Can J Microbiol        ISSN: 0008-4166            Impact factor:   2.419


  8 in total

1.  Comparison of caprine, human and bovine strains of respiratory syncytial virus.

Authors:  M Trudel; F Nadon; C Simard; F Bélanger; R Alain; C Séguin; G Lussier
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

2.  Immunodominant T-cell epitope on the F protein of respiratory syncytial virus recognized by human lymphocytes.

Authors:  M E Levely; C A Bannow; C W Smith; J A Nicholas
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

3.  Synthetic peptides corresponding to the F protein of RSV stimulate murine B and T cells but fail to confer protection.

Authors:  M Trudel; E J Stott; G Taylor; D Oth; G Mercier; F Nadon; C Séguin; C Simard; M Lacroix
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

4.  Amino acid variation within the fusion protein of respiratory syncytial virus subtype A and B strains during annual epidemics in South Africa.

Authors:  Elizabeth Agenbach; Caroline T Tiemessen; Marietjie Venter
Journal:  Virus Genes       Date:  2005-03       Impact factor: 2.332

5.  Antigenic analysis of the F protein of the bovine respiratory syncytial virus: identification of two distinct antigenic sites involved in fusion inhibition.

Authors:  J P Matheise; K Walravens; A Collard; P Coppe; J J Letesson
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

6.  Relationship between the loss of neutralizing antibody binding and fusion activity of the F protein of human respiratory syncytial virus.

Authors:  Changbao Liu; Nicole D Day; Patrick J Branigan; Lester L Gutshall; Robert T Sarisky; Alfred M Del Vecchio
Journal:  Virol J       Date:  2007-07-10       Impact factor: 4.099

7.  Immunodominant T-cell epitopes of rubella virus structural proteins defined by synthetic peptides.

Authors:  M McCarthy; A Lovett; R H Kerman; A Overstreet; J S Wolinsky
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

8.  Involvement of the complement system in the protection of mice from challenge with respiratory syncytial virus Long strain following passive immunization with monoclonal antibody 18A2B2.

Authors:  S Corbeil; C Seguin; M Trudel
Journal:  Vaccine       Date:  1996-04       Impact factor: 3.641

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.